Wu Eva L, Desai Parind M, Zaidi Syed A M, Elkes Richard, Acharya Shreyas, Truong Triet, Armstrong Cameron
Analytical Platforms and Platform Modernization, CMC Analytical, GlaxoSmithKline (GSK) R&D, Collegeville, Pennsylvania, USA.
Process Engineering & Analytics, Pharmaceutical Development, GlaxoSmithKline (GSK) R&D, Collegeville, Pennsylvania, USA.
Eur J Pharm Sci. 2021 Apr 1;159:105702. doi: 10.1016/j.ejps.2021.105702. Epub 2021 Jan 9.
Due to the complexity in the interactions of variables and mechanisms leading to blend segregation, quantifying the segregation propensity of an Active Pharmaceutical Ingredient (API) has been challenging. A high-throughput segregation risk prediction workflow for early drug product development has been developed based on the dispensing mechanism of automated powder dispensing technology. The workflow utilized liquid handling robots and high-performance liquid chromatography (HPLC) with a well-plate autosampler for sample preparation and analysis. Blends containing three different APIs of varying concentrations and particle sizes of different constituents were evaluated through this automated workflow. The workflow enabled segregation evaluation of different API blends in very small quantities (~7g) compared to other common segregation testers that consume hundreds of grams. Segregation patterns obtained were well explained with vibration induced percolation-based segregation phenomena. Segregation risk was translated quantitatively using relative standard deviation (RSD) calculations, and the results matched well with large-scale segregation studies. The applied approach increased the throughput, introduced a simple and clean walk-up method with minimized equipment space and API exposures to conduct segregation studies. Results obtained can provide insights about optimizing particle size distributions, as well as selecting appropriate formulation constituents and secondary processing steps in early drug product development when the amount of available API is very limited.
由于导致混合物料离析的变量和机制之间相互作用复杂,定量测定活性药物成分(API)的离析倾向一直具有挑战性。基于自动粉末分装技术的分装机制,已开发出一种用于早期药物产品开发的高通量离析风险预测工作流程。该工作流程利用液体处理机器人和配备微孔板自动进样器的高效液相色谱(HPLC)进行样品制备和分析。通过这种自动化工作流程,对含有三种不同浓度和不同成分粒径的API的混合物进行了评估。与其他消耗数百克物料的常见离析测试仪相比,该工作流程能够对极少量(约7克)的不同API混合物进行离析评估。所获得的离析模式可以用基于振动诱导渗流的离析现象很好地解释。使用相对标准偏差(RSD)计算对离析风险进行定量转化,结果与大规模离析研究结果吻合良好。所应用的方法提高了通量,引入了一种简单、清洁的直接操作方法,所需设备空间和API暴露量最小,可用于进行离析研究。当可用API量非常有限时,所获得的结果可为早期药物产品开发中优化粒径分布、选择合适的制剂成分和二次加工步骤提供参考。